Ann Cunningham

Ann Cunningham

Director/Miembro de la Junta en VISTAGEN THERAPEUTICS, INC. .

Fortuna: - $ al 31/05/2026

58 años
Health Technology
Consumer Services

Perfil

Ann Cunningham is the founder of I3 Strategy Partners LLC.
Ms. Cunningham is currently an Independent Director at Vistagen Therapeutics, Inc. since 2022 and an Independent Non-Executive Director at Alterity Therapeutics Ltd. starting in 2026.
Formerly, Ms. Cunningham was Senior Director-Global Brand at Eli Lilly & Co. from 1999 to 2013, Senior Marketing Director at Otsuka America Pharmaceutical, Inc. from 2013 to 2015, and Vice President-Neurodegenerative Disease at Teva Pharmaceutical Industries Ltd. from 2015 to 2018.
Ms. Cunningham completed undergraduate studies at Yale University and earned an MBA from Stephen M.
Ross School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
09/09/2025 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Ann Cunningham

EmpresasCargoInicio
VISTAGEN THERAPEUTICS, INC. Director/Miembro de la Junta 10/01/2019
ALTERITY THERAPEUTICS LIMITED Director/Miembro de la Junta 17/04/2026

Antiguos cargos conocidos de Ann Cunningham.

EmpresasCargoFin
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2018
Corporate Officer/Principal 01/01/2015
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2013
I3 Strategy Partners LLC
Fundador -
Ver el detalle de la experiencia de Ann Cunningham.

Formación de Ann Cunningham.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

69

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

I3 Strategy Partners LLC